[Corneal, conjunctival and lacrimal changes (excluding dry eye)].
George
J L
JL
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000638:Amiodarone / Q000009:adverse effects; D000779:Anesthetics, Local / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D002738:Chloroquine / Q000009:adverse effects; D003229:Conjunctival Diseases / Q000139:chemically induced*; D003261:Contact Lenses; D003316:Corneal Diseases / Q000139:chemically induced*; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000139:chemically induced*; D009883:Ophthalmic Solutions; D010640:Phenothiazines; D010859:Pigmentation Disorders / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D014150:Antipsychotic Agents; D000998:Antiviral Agents; D009883:Ophthalmic Solutions; D010640:Phenothiazines; D002738:Chloroquine; D000638:Amiodarone
Les altérations cornéennes, conjonctivales et lacrymales (à l'exclusion de l'oeil sec).